Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Depakote [valproate semisodium] ER [extended release] vs seroquel [quetiapine] for agitated behaviors in nursing home care unit patients with dementia

Next Previous
X
Search
Trial Profile

Depakote [valproate semisodium] ER [extended release] vs seroquel [quetiapine] for agitated behaviors in nursing home care unit patients with dementia

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 01 Aug 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Quetiapine (Primary) ; Valproate semisodium
  • Indications Dementia
  • Focus Therapeutic Use

    • Most Recent Events

    • 25 Apr 2017 Status changed from completed to discontinued.
    • 31 Aug 2012 Actual end date (1 Mar 2008) added as reported by ClinicalTrials.gov record.
    • 31 Aug 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top